Delivery Order SPE2DB24D3013-SPE2DB26FFFXM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $1,026.44. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger contract vehicle with the agency. The order will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $4,907.16 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units), with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order, which represents no set-aside designation, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under a child delivery order structure, indicating it is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $2,168.86. This is a firm fixed-price delivery order with no set-aside designation, performed competitively. The order is scheduled for completion by July 16, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trokendi XR 200 mg capsules (30-count) with a ceiling value of $4,581.65. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by November 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,392.42. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) with a contract value of $3,085.77. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by September 18, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,309.32 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Trokendi XR 25 mg capsules (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,180.32 to AmerisourceBergen Drug Corp for Trokendi XR 50 mg capsules (30-count) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trokendi XR 100 mg capsules in a quantity of 30 units, with a ceiling value of $3,281.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is executed...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFXMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Trokendi XR 50 mg capsules (30-count units) with a contract value of $1,329.74. This non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by October 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction typical of routine pharmaceutical procurement operations supporting federal military and healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for the Defense Health Agency and military healthcare programs, supplying a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic areas. The competitively awarded parent IDC demonstrates the contractor's capability to fulfill diverse federal medical supply requirements on a global scale, with this particular delivery order addressing anticonvulsant medication needs within that broader supply framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/28/25 |